(Q36415100)

14 August 2017

1 reference

title

Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology (English)

1 reference

intraepithelial neoplasia

14 August 2017

1 reference

1 reference

based on heuristic

inferred from title

prostatic intraepithelial neoplasia

1 reference

Alan K Meeker

1

1 reference

14 August 2017

language of work or name

1 reference

1 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

24

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

122-130

1 reference

Pathological and molecular aspects of prostate cancer

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

The molecular genetics of prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Cancer genes and the pathways they control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Principles of tumor suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

p53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase fish analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Genetic alterations in hormone-refractory recurrent prostate carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Genetic instabilities in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Numerical chromosomal changes in high-grade prostatic intraepithelial neoplasia (PIN) and concomitant invasive carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

DNA repair and tumorigenesis: lessons from hereditary cancer syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Conservation of the human telomere sequence (TTAGGG)n among vertebrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Assessment of telomere length and factors that contribute to its stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomere repeat binding factors: keeping the ends in check

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomeres shorten during ageing of human fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

In vivo loss of telomeric repeats with age in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomere reduction in human colorectal carcinoma and with ageing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomere end-replication problem and cell aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

DNA damage and repair in telomeres: relation to aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Identification of a specific telomere terminal transferase activity in Tetrahymena extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Alternative lengthening of telomeres, telomerase, and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

DNA amplification by breakage/fusion/bridge cycles initiated by spontaneous telomere loss in a human cancer cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

A critical role for telomeres in suppressing and facilitating carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomere dysfunction and the initiation of genome instability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Cellular senescence as a tumor-protection mechanism: the essential role of counting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomere dysfunction provokes regional amplification and deletion in cancer genomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

The 14-3-3 cancer connection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Association between cancer-free survival and telomere DNA content in prostate tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Extension of life-span by introduction of telomerase into normal human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Creation of human tumour cells with defined genetic elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

A survey of telomerase activity in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomerase activity in human benign prostate tissue and prostatic adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomerase activity in primary prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Focal intratumoral heterogeneity for telomerase activity in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

An appraisal of telomerase activity in benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomerase activity in needle biopsies from prostate cancer and benign prostates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomerase activity in touch-imprint cell preparations from fresh prostate needle biopsy specimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Biopsying prostate gland: telomerase evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Detection of telomerase activity in prostate needle-biopsy samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Determination of the enzyme telomerase in needle biopsies and fine needle aspiration cytology samples of the prostate in the diagnosis of prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomerase activity in prostate sextant needle cores from radical prostatectomy specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Detection of telomerase activity in prostatic fluid specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Expression of TERT in early premalignant lesions and a subset of cells in normal tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Expression-patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

A telomerase component is defective in the human disease dyskeratosis congenita

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Functional requirement of p23 and Hsp90 in telomerase complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Identification of two RNA-binding proteins associated with human telomerase RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

A mammalian telomerase-associated protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Putative Telomere-Recruiting Domain in the Catalytic Subunit of Human Telomerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Human chromosome 5 carries a putative telomerase repressor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Multiple tumor suppressor pathways negatively regulate telomerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Polycomb CBX7 has a unifying role in cellular lifespan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Telomerase is activated in the prostate and seminal vesicles of the castrated rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Androgen depletion activates telomerase in the prostate of the nonhuman primate, Macaca mulatta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Signaling through estrogen receptors modulates telomerase activity in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

The effects of natural ligands of hormone receptors and their antagonists on telomerase activity in the androgen sensitive prostatic cancer cell line LNCaP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Microarray analysis of bicalutamide action on telomerase activity, p53 pathway and viability of prostate carcinoma cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

In vivo regulation of hTERT expression and telomerase activity by androgen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Cloning and characterization of human and mouse telomerase RNA gene promoter sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Androgen-induced cell growth and c-myc expression in human non-transformed epithelial prostatic cells in primary culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

International trends and patterns of prostate cancer incidence and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Oxidative stress shortens telomeres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.002

10.1016/J.UROLONC.2005.11.002

7 January 2021

Identifiers

DOI

1 reference

14 August 2017

1 reference